Ms Alexandra van Dissel

Back

Ms Alexandra van Dissel

Amsterdam UMC - Location Academic Medical Center, Amsterdam (Netherlands (The))

Presentations

Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Congenital Heart Disease and Pediatric Cardiology ePosters

Access

Refining the 2015 European guidelines risk assessment tool for pulmonary arterial hypertension in adult congenital heart disease

Event: ESC CONGRESS 2019

Topic: Adult Congenital Heart Disease (ACHD)

Session: Clinical aspects in congenital heart disease

Access

Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Risk stratification in congenital heart disease

Access

Systemic right ventricular function: temporal trends and risk for events

Event: ESC Congress 2018

Topic: Cardiac Magnetic Resonance (CMR)

Session: Congenital heart disease diagnostic aspects

Access

A congenital anomaly underlying mitral valve disease.

Event: ESC Congress 2018

Topic: Clinical

Session: Squaring the circle: from congenital to acquired complex valvular and myocardial disease

Access

QRS complex in adults with systemic right ventricles: signs of poor prognosis

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Novel insights in congenital heart disease

Access

A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Novel insights in congenital heart disease

Access

Long-term clinical outcomes of a randomized controlled trial comparing valsartan to placebo in patients with systemic right ventricles

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Contemporary management of risk factors in congenital heart disease

Access

Ms Alexandra van Dissel

Contributor content

Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease

Refining the 2015 European guidelines risk assessment tool for pulmonary arterial hypertension in adult congenital heart disease

Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study

Systemic right ventricular function: temporal trends and risk for events

A congenital anomaly underlying mitral valve disease.

QRS complex in adults with systemic right ventricles: signs of poor prognosis

A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality

Long-term clinical outcomes of a randomized controlled trial comparing valsartan to placebo in patients with systemic right ventricles

This platform is supported by